Literature DB >> 11164427

Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients.

M P Schlaich1, S John, J Jacobi, K J Lackner, R E Schmieder.   

Abstract

BACKGROUND: Elevated low density lipoproteins (LDL)-cholesterol and homocysteine levels have both been found to be associated with an increased risk for atherosclerotic vascular disease. To assess the effects of elevated homocysteine levels in hypercholesterolemic subjects on endothelial function, we examined basal and stimulated nitric oxide (NO) mediated vasodilation in the forearm vascular bed in hypercholesterolemic subjects with normal or elevated homocysteine levels.
METHODS: Twenty-seven white subjects (age: 48 +/- 12 years) with elevated LDL-cholesterol (> or = 160 mg/dl) were divided into two groups with normal (n = 11) or mildly elevated (n = 16) homocysteine plasma concentration. We used strain gauge plethysmography to measure changes in forearm blood flow in response to intraarterial administration of increasing doses of acetylcholine (3, 12, 24, 48 microg/min), sodium nitroprusside (200, 800, 3200 ng/min), and N-monomethyl L-arginine (L-NMMA) (1, 2, 4 micromol/min). Total homocysteine plasma concentrations were determined by high performance liquid chromatography fluorimetry.
RESULTS: Endothelium independent vascular relaxation tested by i.a. sodium nitroprusside and changes in forearm blood flow after i.a. L-NMMA indicating basal production and release of nitric oxide were similar between the two groups with normal or elevated homocysteine levels. In contrast, endothelium dependent vasodilation as assessed by the administration of i.a. acetylcholine differed between the groups with normal or elevated homocysteine levels for all doses tested (MANOVA P < 0.01: ACH 48 microg/min: 480 +/- 237% with normal vs 234 +/- 130% with elevated homocysteine; P < 0.002). This was significant even after taking possible covariates such as age, blood pressure, body mass index, LDL-, high density lipoproteins (HDL)-cholesterol, and trigylcerides into account (MANOVA P < 0.02).
CONCLUSIONS: From our study we conclude that homocysteine impairs endothelium dependent vasodilation in subjects with elevated LDL-cholesterol levels. The most intriguing finding is that even mildly elevated homocysteine levels seem to be of crucial importance for deterioration of endothelial function, especially if other cardiovascular risk factors such as hypercholesterolemia preexist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11164427     DOI: 10.1016/s0021-9150(00)00412-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

Review 1.  Homocysteine and atherothrombosis: diagnosis and treatment.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  Hyperhomocysteinemia and Low Folate and Vitamin B12 Are Associated with Vascular Dysfunction and Impaired Nitric Oxide Sensitivity in Morbidly Obese Patients.

Authors:  Mohamed Haloul; Smita Jagdish Vinjamuri; Dina Naquiallah; Mohammed Imaduddin Mirza; Maryam Qureshi; Chandra Hassan; Mario Masrur; Francesco M Bianco; Patrice Frederick; Giulianotti P Cristoforo; Antonio Gangemi; Mohamed M Ali; Shane A Phillips; Abeer M Mahmoud
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

3.  Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy.

Authors:  Revathy Carnagarin; Janis M Nolde; Natalie C Ward; Leslie Marisol Lugo-Gavidia; Justine Chan; Sandi Robinson; Ancy Jose; Anu Joyson; Omar Azzam; Márcio Galindo Kiuchi; Bibombe P Mwipatayi; Markus P Schlaich
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-06-17       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.